Patents by Inventor Michael John Hall

Michael John Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10342901
    Abstract: Provided are drainage systems that may include a drainage manifold and may be suitable for draining fluid from a tissue site. The drainage manifold may include a plurality of elongate members having a moveable end that may be adapted to configure the drainage manifold to treat a uniquely shaped tissue site. The drainage manifold may be coupled to a drainage tube with a transitional connector to provide a drainage system capable of distributing reduced pressure to the tissue site to enhance the drainage of fluids.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: July 9, 2019
    Assignee: IC Surgical, Inc.
    Inventors: Douglas A. Cornet, Michael Manwaring, Edward Sy Griffey, Erin Black, Colin John Hall, Jonathan Kagan
  • Patent number: 10300173
    Abstract: The invention relates to compounds, compositions and methods for biofilm disruption and prevention. In particular, the invention relates to pharmaceutical compositions for the disruption of biofilm and prevention of biofilm in patients. The invention also relates to anti-biofouling compositions for the disruption of biofilm and prevention of biofilm on surfaces. The invention also relates to the removal of biological material from surfaces. The compositions of the invention include microbial deoxyribonucleases.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: May 28, 2019
    Assignee: University of Newcastle Upon Tyne
    Inventors: James Grant Burgess, Michael John Hall, Reindert Nijland
  • Publication number: 20170340779
    Abstract: The invention relates to compounds, compositions, and methods for biofilm disruption and prevention. In particular, the invention relates to pharmaceutical compositions for the disruption of biofilm and prevention of biofilm in patients. The invention also relates to anti-biofouling compositions for the disruption of biofilm and prevention of biofilm on surfaces. The invention also relates to the removal of biological material from surfaces. The compositions of the invention include microbial deoxyribonucleases.
    Type: Application
    Filed: May 4, 2017
    Publication date: November 30, 2017
    Applicant: University of New Castle Upon Tyne
    Inventors: James Grant Burgess, Michael John Hall, Reindert Nijland
  • Publication number: 20170333601
    Abstract: The invention relates to compounds, compositions and methods for biofilm disruption and prevention. In particular, the invention relates to pharmaceutical compositions for the disruption of biofilm and prevention of biofilm in patients. The invention also relates to anti-biofouling compositions for the disruption of biofilm and prevention of biofilm on surfaces. The invention also relates to the removal of biological material from surfaces. The compositions of the invention include microbial deoxyribonucleases.
    Type: Application
    Filed: May 4, 2017
    Publication date: November 23, 2017
    Inventors: James Grant Burgess, Michael John Hall, Reindert Nijland
  • Patent number: 9675736
    Abstract: The invention relates to compounds, compositions and methods for biofilm disruption and prevention. In particular, the invention relates to pharmaceutical compositions for the disruption of biofilm and prevention of biofilm in patients. The invention also relates to anti-biofouling compositions for the disruption of biofilm and prevention of biofilm on surfaces. The invention also relates to the removal of biological material from surfaces. The compositions of the invention include microbial deoxyribonucleases.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: June 13, 2017
    Assignee: UNIVERSITY OF NEWCASTLE UPON TYNE
    Inventors: James Grant Burgess, Michael John Hall, Reindert Nijland
  • Publication number: 20130052250
    Abstract: The invention relates to compounds, compositions and methods for biofilm disruption and prevention. In particular, the invention relates to pharmaceutical compositions for the disruption of biofilm and prevention of biofilm in patients. The invention also relates to anti-biofouling compositions for the disruption of biofilm and prevention of biofilm on surfaces. The invention also relates to the removal of biological material from surfaces. The compositions of the invention include microbial deoxyribonucleases.
    Type: Application
    Filed: February 11, 2011
    Publication date: February 28, 2013
    Applicant: UNIVERSITY OF NEWCASTLE UPON TYNE
    Inventors: James Grant Burgess, Michael John Hall, Reindert Nijland
  • Patent number: 4100275
    Abstract: Compositions having antibiotic properties containing as antibiotic potentiators peptides of the formula ##STR1## wherein R.sup.1 represents a hydrogen atom or a lower alkyl, lower cycloalkyl, (lower cycloalkyl)-(lower alkyl), aryl or aryl(lower alkyl) group (said group being optionally substituted as the case may require by one or more amino, hydroxy, thio, methylthio, carboxy or guanidino groups so as to form the characterizing group of a naturally occurring L .alpha.-amino acid); R.sup.2 and R.sup.3 each represent the characterizing group of an .alpha.-amino acid of the type normally found in proteins with the proviso that R.sup.3 cannot represent a hydrogen atom when n is zero and R.sup.1 is a hydrogen atom or the phenyl group; R.sup.4 represents a hydroxy or methyl group; n stands for zero, 1, 2 or 3; and single asterisks denote that the configuration at the carbon atom so-marked is L when R.sup.2 or R.sup.
    Type: Grant
    Filed: July 21, 1976
    Date of Patent: July 11, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank Ratcliffe Atherton, Michael John Hall, Cedric Herbert Hassall, Peter Stuart Ringrose, Robert Wilson Lambert
  • Patent number: 4016148
    Abstract: The present disclosure relates to peptide derivatives. More particularly, the disclosure is concerned with peptide derivatives of phosphonic and phosphinic acids, a process for the manufacture thereof and pharmaceutical preparations containing same.
    Type: Grant
    Filed: January 19, 1976
    Date of Patent: April 5, 1977
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank Ratcliffe Atherton, Michael John Hall, Cedric Herbert Hassall, Peter Stuart Ringrose, Robert Wilson Lambert